Results 31 to 40 of about 7,205 (191)

CRISPR/Cas-based detection systems – emerging tools for plant pathology

open access: yesOpen Agriculture
Plant diseases pose a significant threat to global food security, causing substantial crop yield losses and economic damage. Traditional diagnostic methods often lack the speed, specificity, and sensitivity required for effective disease management.
Pozharskiy Alexandr   +4 more
doaj   +1 more source

A CRISPR Test for Detection of Circulating Nuclei Acids

open access: yesTranslational Oncology, 2019
Emerging CRISPR-based nucleic acid detection shows great promise in molecular diagnosis of diseases. CRISPR-Cas12a can sensitively and specifically detect human papillomavirus (HPV) DNA in anal swabs.
Jen-Hui Tsou, Qixin Leng, Feng Jiang
doaj   +1 more source

Enhanced Cas12a editing in mammalian cells and zebrafish

open access: yesNucleic Acids Research, 2019
Type V CRISPR-Cas12a systems provide an alternate nuclease platform to Cas9, with potential advantages for specific genome editing applications. Here we describe improvements to the Cas12a system that facilitate efficient targeted mutagenesis in mammalian cells and zebrafish embryos. We show that engineered variants of Cas12a with two different nuclear
Liu, Pengpeng   +15 more
openaire   +3 more sources

Inhibition of CRISPR-Cas12a DNA targeting by nucleosomes and chromatin [PDF]

open access: yesScience Advances, 2020
CRISPR-Cas12a cuts DNA in liquid-like chromatin condensates but is inhibited near nucleosomes.
Isabel Strohkendl   +5 more
openaire   +3 more sources

Transport–Reaction–Signal Coupling in Lateral Flow Assays for Next‐Generation Point‐of‐Care Diagnostics

open access: yesAdvanced Science, EarlyView.
Lateral flow assays are evolving into interdisciplinary, system‐level sensing platforms. Recent innovations are deconstructed through coupled phases of mass transfer, reaction, and signal transduction, revealing interdependence across porous materials, interfacial chemistry, nanolabels, readout devices, and data‐enabled analysis.
Yan Pan   +6 more
wiley   +1 more source

Rapid detection of feline parvovirus using RAA-CRISPR/Cas12a-based lateral flow strip and fluorescence

open access: yesFrontiers in Microbiology
Feline parvovirus (FPV) causes severe gastroenteritis and leukopenia in cats, with high morbidity and mortality, necessitating a rapid and effective antigen diagnostic test with high sensitivity and specificity. In this study, a diagnostic platform based
Han Chen   +16 more
doaj   +1 more source

Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds

open access: yesGenome Biology, 2019
CRISPR-Cas12a/Cpf1, a single RNA-guided endonuclease system, provides a promising tool for genome engineering. However, only three Cas12a orthologs have been employed for mammalian genome editing, and the editing efficiency as well as targeting coverage ...
Fei Teng   +10 more
doaj   +1 more source

Co-freezing localized CRISPR-Cas12a system enables rapid and sensitive nucleic acid analysis

open access: yesJournal of Nanobiotechnology
Rapid and sensitive nucleic acid detection is vital in disease diagnosis and therapeutic assessment. Herein, we propose a co-freezing localized CRISPR-Cas12a (CL-Cas12a) strategy for sensitive nucleic acid detection.
Lifeng Zhang   +11 more
doaj   +1 more source

MnO2 Nanosponge‐Accelerated Cas12a Trans‐Cleavage: Breaking the Kinetic Barrier for In Vivo RNA Imaging

open access: yesAdvanced Science
CRISPR/Cas12a system has emerged as a promising tool for in vitro biosensing, but its in vivo applications are hindered by its inefficient intracellular delivery and suboptimal trans‐cleavage kinetics.
Wen‐jing Liu   +3 more
doaj   +1 more source

Point-of-care testing of rpoB in Mycobacterium tuberculosis using multiply-primed-RCA coupled with CRISPR/Cas12a

open access: yesHeliyon
Purpose: Due to the serious threat of tuberculosis to global health and limitations of existing diagnostic methods, this study combined the CRISPR/Cas12a system with Multiply-primed-RCA (MRCA) technology for Mycobacterium tuberculosis Point-of-care ...
Yingying Sun   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy